Cas 1246375-05-2,N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide

1246375-05-2

Post Buying Request

Basic information

Product Name: N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide
Synonyms: N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide
CAS NO:1246375-05-2
Molecular Formula:
Molecular Weight: 443.567
EINECS: N/A
Product Categories: N/A
Mol File: 1246375-05-2.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide(CAS DataBase Reference)
NIST Chemistry Reference: N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide(1246375-05-2)
EPA Substance Registry System: N-hydroxy-7-(N-(4-(1-methyl-1H-indol-5-yl)phenyl)methylsulfonamido)heptanamide(1246375-05-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1246375-05-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1246375-05-2 Suppliers

Recommended suppliersmore

1246375-05-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1246375-05-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,3,7 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1246375-05:
(9*1)+(8*2)+(7*4)+(6*6)+(5*3)+(4*7)+(3*5)+(2*0)+(1*5)=152
152 % 10 = 2
So 1246375-05-2 is a valid CAS Registry Number.

1246375-05-2Upstream product

1246375-05-2Downstream Products

1246375-05-2Relevant articles and documents

NOVEL HYDROXAMATE DERIVATIVE, A PRODUCTION METHOD FOR THE SAME, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

-

, (2012/02/06)

The present invention relates to hydroxamate derivatives, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof, or solvates thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1246375-05-2